YARROW BIOSCIENCE, INC. Increase (Decrease) in Other Noncurrent Liabilities
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Other Noncurrent Liabilities of -$1.21 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2022-03-17
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2021-12-31 was -$1.21M, a 120700.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-12-31 was $1.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2019-12-31 was -$251.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2019-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$1.21M, a 121300.00% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2020 was $1.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2019 was -$258.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2018 was -$274.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$1.21M 10-K · filed 2022-03-17 | |||
| 2021-09-30 | -$6.00K 10-Q · filed 2021-11-10 | ||||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.00K 10-K · filed 2022-03-17 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | ||||
| 2019-12-31 | -$251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$251.00K derived: sum of 2 quarters · filed 2021-03-04 | -$251.00K derived: sum of 3 quarters · filed 2021-03-04 | -$258.00K 10-K · filed 2021-03-04 | -$7.00K 10-K · filed 2020-03-03 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | -$7.00K 10-Q · filed 2019-10-31 | -$271.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$7.00K 10-Q · filed 2019-08-01 | -$271.00K derived: sum of 3 quarters · filed 2021-03-04 | -$337.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2019-03-31 | -$7.00K 10-Q · filed 2019-05-02 | -$271.00K derived: sum of 2 quarters · filed 2021-03-04 | -$337.00K derived: sum of 3 quarters · filed 2021-03-04 | -$285.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2018-12-31 | -$264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$330.00K derived: sum of 2 quarters · filed 2021-03-04 | -$278.00K derived: sum of 3 quarters · filed 2021-03-04 | -$274.00K 10-K · filed 2021-03-04 | -$15.00K 10-K · filed 2019-02-28 |
| 2018-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$14.00K derived: sum of 2 quarters · filed 2019-10-31 | -$10.00K 10-Q · filed 2019-10-31 | -$6.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $56.00K 10-Q · filed 2019-08-01 | $60.00K derived: sum of 3 quarters · filed 2020-03-03 | $60.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2018-03-31 | $4.00K 10-Q · filed 2019-05-02 | $8.00K derived: sum of 2 quarters · filed 2020-03-03 | $8.00K derived: sum of 3 quarters · filed 2020-03-03 | $5.00K derived: sum of 4 quarters · filed 2020-03-03 | |
| 2017-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $4.00K derived: sum of 2 quarters · filed 2020-03-03 | $1.00K derived: sum of 3 quarters · filed 2020-03-03 | -$12.00K 10-K · filed 2020-03-03 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$3.00K derived: sum of 2 quarters · filed 2018-11-07 | -$16.00K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$16.00K 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | -$13.00K 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | $7.00K 10-K · filed 2019-02-28 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |